Track open bid opportunities, contracts, public meetings, and key contacts for West Virginia Bureau for Medical Services.
Key metrics and characteristics
City
The city where this buyer is located.
Charleston
County
The county where this buyer is located.
Kanawha
Address
Physical address of this buyer.
350 Capitol Street Room 251
Phone Number
Contact phone number for this buyer.
(304) 558-1700
Zip Code
Postal code for this buyer's location.
25301
Propensity to Spend
How likely this buyer is to spend on new technology based on operating budget trends.
AI Adoption Score
How likely this buyer is to adopt new AI technologies.
Startup Friendliness
How often this buyer champions startups and early adoption.
Latest Budget Year
Unlock to view
Operating Budget
Unlock to view
Includes fiscal year calendars, procurement complexity scores, and strategic insights.
Board meetings and strategic plans from West Virginia Bureau for Medical Services
The 2024-2027 West Virginia Managed Care Quality Strategy serves as a framework to guide the West Virginia Department of Human Services, Bureau for Medical Services, in providing quality healthcare services for all Medicaid and WVCHIP members. The plan outlines five key goals: improving health and wellness through preventive services, reducing the burden of chronic diseases, enhancing behavioral health outcomes, decreasing the burden of substance use disorders, and empowering individuals for whole-person wellness and self-management. This strategy aims to drive improvements in care delivery and overall health outcomes by setting clear directions for interventions, standards, and metrics to address critical health challenges within the state.
This 2024-2027 Managed Care Quality Strategy outlines a framework for the West Virginia Department of Human Services, Bureau for Medical Services (BMS), to deliver high-quality healthcare services for Medicaid and WVCHIP members. The plan is structured around five core goals: improving preventive care and overall health, reducing chronic disease burden, enhancing behavioral health outcomes, combating substance use disorders, and promoting whole-person wellness and self-management. The strategy aims to achieve these by strengthening quality and performance improvement, implementing targeted interventions, and aligning with national quality standards to improve health outcomes for vulnerable populations in West Virginia.
The Board received updates regarding the Preferred Drug List status from the Pharmaceutical and Therapeutics Committee meeting. Several proposed prior authorization criteria were reviewed and approved, including criteria for Yorvipath, Dupixent, Alyftrek, Fluticasone HFA, Asmanex HFA, Zurzuvae (as amended), Casgevy, and Lyfgenia. Additionally, the Board reviewed fourth-quarter reports for 2024, including the Gainwell Technologies quarterly report, the Rational Drug Therapy Program summary, and the Acentra Health summary of retrospective DUR interventions.
Extracted from official board minutes, strategic plans, and video transcripts.
Track West Virginia Bureau for Medical Services meetings, strategic plans, and budget discussions before the public bid appears.
Early signals from meeting minutes and plans
Vendor mentions and competitor tracking
Decision timeline from discussion to RFP
Public-sector contacts connected to West Virginia Bureau for Medical Services.
Quotable insights from buyer leadership
